Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
China · Delayed Price · Currency is CNY 4.700
-0.020 (-0.42%)
Jul 30, 2026, 3:04 PM CST
SHE:300239 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,740 | 3,417 | 3,716 | 3,698 | 4,452 | 4,185 | |
Market Cap Growth | -22.93% | -8.06% | 0.48% | -16.93% | 6.38% | 34.56% |
Enterprise Value | 2,787 | 3,431 | 3,553 | 3,715 | 4,525 | 4,019 |
Last Close Price | 4.70 | 5.85 | 6.22 | 6.16 | 7.39 | 6.94 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 53.56 | 62.88 | 43.22 | 30.85 | 40.68 | 114.71 |
Forward PE | - | 60.46 | 60.46 | 60.46 | 60.46 | 60.46 |
PS Ratio | 3.66 | 4.58 | 4.20 | 3.80 | 4.72 | 6.84 |
PB Ratio | 1.57 | 1.98 | 2.14 | 1.95 | 2.54 | 2.61 |
P/TBV Ratio | 1.70 | 2.15 | 2.33 | 2.44 | 3.24 | 3.35 |
P/FCF Ratio | 57.79 | 128.20 | - | 55.07 | 51.32 | 27906.22 |
P/OCF Ratio | 16.67 | 32.26 | 53.75 | 18.55 | 22.79 | 81.26 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.73 | 4.60 | 4.01 | 3.81 | 4.80 | 6.57 |
EV/EBITDA Ratio | 17.93 | 22.73 | 19.34 | 17.06 | 21.53 | 45.07 |
EV/EBIT Ratio | 50.11 | 63.76 | 36.54 | 27.36 | 36.31 | 118.73 |
EV/FCF Ratio | 58.78 | 128.74 | - | 55.32 | 52.16 | 26798.13 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.29 | 0.29 | 0.28 | 0.25 | 0.11 | 0.03 |
Debt / EBITDA Ratio | 3.25 | 3.30 | 2.61 | 2.15 | 0.93 | 0.57 |
Debt / FCF Ratio | 10.66 | 18.70 | - | 6.98 | 2.25 | 336.86 |
Net Debt / Equity Ratio | 0.03 | 0.01 | -0.03 | -0.15 | -0.09 | -0.11 |
Net Debt / EBITDA Ratio | 0.30 | 0.11 | -0.29 | -1.29 | -0.77 | -1.97 |
Net Debt / FCF Ratio | 0.99 | 0.60 | 6.65 | -4.17 | -1.86 | -1169.31 |
Asset Turnover | 0.29 | 0.29 | 0.33 | 0.39 | 0.43 | 0.35 |
Inventory Turnover | 1.50 | 1.55 | 2.16 | 2.43 | 2.15 | 1.63 |
Quick Ratio | 3.00 | 3.12 | 2.68 | 3.50 | 2.20 | 1.27 |
Current Ratio | 4.81 | 4.87 | 3.81 | 4.49 | 3.24 | 2.12 |
Return on Equity (ROE) | 3.18% | 3.14% | 5.03% | 6.98% | 6.87% | 2.75% |
Return on Assets (ROA) | 1.35% | 1.30% | 2.27% | 3.36% | 3.52% | 1.20% |
Return on Invested Capital (ROIC) | 2.77% | 2.76% | 5.09% | 7.46% | 7.23% | 2.28% |
Return on Capital Employed (ROCE) | 2.40% | 2.30% | 4.20% | 5.60% | 6.30% | 2.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 2.01% | 1.59% | 2.31% | 3.24% | 2.46% | 0.87% |
FCF Yield | 1.73% | 0.78% | -0.22% | 1.82% | 1.95% | 0.00% |
Dividend Yield | 0.25% | 0.21% | 0.40% | 0.36% | 0.35% | 0.09% |
Payout Ratio | 32.99% | 33.64% | 18.39% | 17.75% | 10.25% | 15.71% |
Buyback Yield / Dilution | 2.86% | 3.24% | -5.72% | -3.12% | -5.25% | -7.89% |
Total Shareholder Return | 3.11% | 3.45% | -5.32% | -2.76% | -4.89% | -7.80% |